January 17, 2025

Ulrik Harrysson has today informed the Board of Directors of his resignation as CEO with immediate effect.

The Board of Directors of SyntheticMR has appointed Vedran Beglerbegovic as new CEO. Vedran has been acting CEO since December 4 2024 while Ulrik has been on medical leave.

Vedran has been part of SyntheticMR since 2021, his latest role was the Chief Operating Officer. He comes with experience of many years within product management and commercialization within MedTech. He has been studying  Applied Physics & Electronical Engineering at Linköping University.

The Board of Directors wants to thank Ulrik for his contributions among employees, customers and investors over the years. 

For further information, please contact:

Staffan Persson, Chairman of the board, phone: +46 70-321 00 98

Vedran Beglerbegovic, CEO, phone: +46 79-077 27 70

This disclosure contains information that SyntheticMR AB is obliged to make public pursuant to the EU Market Abuse Regulation (EU nr 596/2014). The information was submitted for publication, through the agency of the contact person, on 17-01-2025 18:30 CET.

SyntheticMR AB develops and markets innovative software solutions for Magnetic Resonance Imaging (MRI). SyntheticMR AB has developed SyMRI^®, delivering multiple, adjustable contrast images and quantitative data from a single 5-minute scan. The SyMRI product is available in different packages. SyMRI NEURO delivers multiple contrast images, tissue segmentations and quantitative data on the brain. SyMRI MSK provides multiple contrast images and quantitative data for knee and spine anatomies. SyMRI NEURO is CE-marked and FDA 510(k) cleared and SyMRI MSK is CE-marked. SyMRI is a registered trademark in Europe and the USA. SyntheticMR is listed on the Spotlight Stock Market Exchange in Stockholm, Sweden. For more information, visit www.syntheticmr.com.